Abstract.
Sustainable observations suggest that suicidal behaviour by itself may have biological correlates, among which those related to the serotonergic synapse hold the key position. Based on the association of suicide and serotonergic dysfunction, it was proposed that genetic mechanisms affecting suicidal behaviour could be related to the alterations of the genes encoding the elements of 5HT synapse. The present study tested the association of the polymorphism in the serotonin 2C (5HT-2C) receptor coding region (Cys23Ser) with suicide commitment. Study was based on two independent samples, one of German (284 suicide victims versus 297 controls) and other of Slavic/Croatian (118 suicide victims versus 275 controls) ethnicity. No significant differences in allele or genotype frequencies between victims and controls were demonstrated. Results did not provide supporting evidence for the potential involvement of the investigated variants of 5HT-2C receptor in the susceptibility to suicide.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahrens B, Linden M (1996) Is there a suicidality syndrome independent of specific major psychiatric disorder – results of a split half multiple regression analysis. Acta Psychiatr Scand 94:79–86
Albinsson A, Palazidou E, Stephenson J, Andersson G (1994) Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release. Eur J Pharmacol 251:157–161
Arango V, Ernsberger P, Marzuk PM, Chen JS, Tierney H, Stanley M, Reis DJ, Mann JJ (1990) Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 47:1038–1047
Asberg M, Forslund K (2000) Neurobiological aspects of suicidal behaviour. Int Rev Psych 12:62–74
Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083–1152
Brent DA, Bridge J, Johnson BA, Connolly J (1996) Suicidal behavior runs in families. Arch Gen Psychiatry 53:1145–1152
Coccaro EF, Kavoussi RJ, Oakes M, Cooper TB, Hauger R (1996) 5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects. Psychopharmacology 126:24–30
Diekstra RFW (1996) The epidemiology of suicide and parasuicide. Arch Suicide Res 2:1–29
Evans J, Reeves B, Platt H, Leibenau A, Goldman D, Jefferson K, Nutt D (2000) Impulsiveness, serotonin genes and repetition of deliberate self-harm (DSH). Psychol Med 30:1327–1334
Fehr C, Szegedi A, Anghelescu I, Klawe C, Hiemke C, Dahmen N (2000) Sex differences in allelic frequencies of the 5-HT2C Cys23Ser polymorphism in psychiatric patients and healthy volunteers: findings from an association study. Psychiatr Genet 10:59–65
George DT, Benkelfat C, Rawlings RR, Eckardt MJ, Phillips MJ, Nutt DJ, Wynne D, Murphy DL, Linnoila M (1997) Behavioral and neuroendocrine responses to m-chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects. Am J Psychiatry 154:81–87
Kaplan HI, Sadock BJ (1998) Suicide. In: Millet KC (ed) Synopsis of Psychiatry: Behavioral Sciences, Clinical Psychiatry. Williams & Wilkins, Baltimore, pp 864–872
Kennett GA, Wood MD, Bright F, Trail B, Riley G, Holland V, Avenell KY, Stean T, Upton N, Bromidge S, Forbes IT, Brown AM, Middlemiss DN, Blackburn TP (1997) SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology 36:609–620
Lappalainen J, Long JC, Virkkunen M, Ozaki N, Goldman D, Linnoila M (1999) HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses. Biol Psychiatry 46:821–826
Lappalainen J, Zhang L, Dean M, Ozaki M, Ozaki N, Yu DH, Virkkunen M, Weight F, Linnoila M, Goldman D (1995) Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HTϰ receptor gene (HTR2C). Genomics 27:274–279
Lerer B, Macciardi F, Segman RH, Adolfsson R, Blackwood D, Blairy S, Del Favero J, Dikeos DG, Kaneva R, Lilli R, Massat I, Milanova V, Muir W, Noethen M, Oruc L, Petrova T, Papadimitriou GN, Rietschel M, Serretti A, Souery D, Van Gestel S, Van Broeckhoven C, Mendlewicz J (2001) Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder. Mol Psychiatry 6:579–585
Malone KM, Corbitt EM, Li S, Mann JJ (1996) Prolactin response to fenfluramine and suicide attempt lethality in major depression. Br J Psychiatry 168:324–329
Mann JJ, Brent DA, Arango V (2001) The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology 24:467–477
Moreau JL, Bos M, Jenck F, Martin JR, Mortas P, Wichmann J (1996) 5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats. Eur Neuropsychopharmacol 6:169–175
Roy A (2001) Genetic influence on suicide risk. Clin Neurosci Res 1:324–330
Turecki G (2001) Suicidal behavior: is there a genetic predisposition? Bipol Disord 3:335–349
Turecki G, Sequeira A, Gingras Y, Seguin M, Lesage A, Tousignant M, Chawky N, Vanier C, Lipp O, Benkelfat C, Rouleau GA (2003) Suicide and serotonin: Study of variation at seven serotonin receptor genes in suicide completers. Am J Med Genet (Neuropsychiatr Genet) 118B:36–40
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stefulj, J., Büttner, A., Kubat, M. et al. 5HT–2C receptor polymorphism in suicide victims. European Archives of Psychiatry and Clinical Neurosciences 254, 224–227 (2004). https://doi.org/10.1007/s00406-004-0482-5
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00406-004-0482-5